
Scientific and Regulatory Perspectives on Mass Spectrometry-based Strategies During Early Stages of Therapeutic Development for COVID-19

Speaker Presentation Rao Ashutosh, CDER, FDA, 2021
Scientific and Regulatory Perspectives on Mass Spectrometry-based Strategies During Early Stages of Therapeutic Development for COVID-19
Scientific and Regulatory Perspectives on Mass Spectrometry-based Strategies During Early Stages of Therapeutic Development for COVID-19